Efficacy and safety of inclisiran in adolescents with heterozygous familial hypercholesterolaemia (ORION-16): a two-part, randomised, multicentre clinical trial

Journal:

The Lancet Diabetes & Endocrinology

Published:

2026-01-28

DOI:

10.1016/s2213-8587(25)00351-1

Affiliations:

14

Authors:

13

Go to article

Institutions	Authors	Share
Amsterdam UMC, Location AMC, Netherlands	2.000000	0.15
Novartis, Switzerland	2.000000	0.15
University of Wisconsin-Madison (UW-Madison), United States of America (USA)	1.000000	0.08
Health Center Ellasanté, France	1.000000	0.08
CHU de Québec, UL, Canada	1.000000	0.08
Hospital Universitario de Navarra (HUN), Spain	1.000000	0.08
Erasmus University Medical Center (Erasmus MC), Netherlands	1.000000	0.08
Novartis China, China	1.000000	0.08
Western University (UWO), Canada	1.000000	0.08
Hospital Israelita Albert Einstein, Brazil	0.500000	0.04
Hospital das Clínicas da FMUSP, Brazil	0.500000	0.04
University Medical Center Freiburg, Germany	0.500000	0.04
MVZ-Clotten Oltmannstrasse, Germany	0.500000	0.04

Interested in Medical Biotechnology?